Reversal of drug resistance in Trypanosoma cruzi and Leishmania donovani by verapamil
- 1 March 1989
- journal article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 83 (2) , 197-198
- https://doi.org/10.1016/0035-9203(89)90642-1
Abstract
Following previous studies of verapamil reversal of chloroquine resistance in malaria and multi-drug resistance in cancer cells, the effect of verapamil was investigated on nifurtimox-resistant Trypanosoma cruzi in vitro and antimony-resistant Leishmania donovani in vitro and in vivo. Verapamil alone was not active against either parasite, but in combination with nifurtimox it reversed the drug resistance of T. cruzi and in combination with sodium stibogluconate reversed the drug resistance of L. donovani.Keywords
This publication has 4 references indexed in Scilit:
- Comparative studies of drug susceptibility of five strains of Trypanosoma cruzi in vivo and in vitroTransactions of the Royal Society of Tropical Medicine and Hygiene, 1988
- Reversal of Chloroquine Resistance in Plasmodium falciparum by VerapamilScience, 1987
- Anti-leishmanial effect of allopurinol ribonucleoside and the related compounds, allopurinol, thiopurinol, thiopurinol ribonucleoside, and of formycin B, sinefungin and the lepidine WR6026Transactions of the Royal Society of Tropical Medicine and Hygiene, 1985
- An in-vitro system for determining the activity of compounds against the intracellular amastigote form of Leishmania donovaniJournal of Antimicrobial Chemotherapy, 1984